Viatris Inc (VTRS)

12.56 +0.16 (+1.33%) USD  |  NASDAQ  |  Dec 26, 16:00
12.59 +0.02 (+0.20%) After-Hours: 16:45
More

Viatris Research and Development Expense (Quarterly): 198.40M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for VTRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Lexicon Pharmaceuticals Inc 25.78M
Moderna Inc 1.137B
Baxter International Inc 129.00M
Gilead Sciences Inc 1.395B
Perspective Therapeutics Inc 12.03M